Global Central Nervous System Drugs Sales Market Report 2017

Global Central Nervous System Drugs Sales Market Report 2017

1 Central Nervous System Drugs Overview

1.1 Product Overview and Scope of Central Nervous System Drugs

1.2 Classification of Central Nervous System Drugs

1.2.1 Type I

1.2.2 Type II

1.3 Application of Central Nervous System Drugs

1.3.1 Application 1

1.3.2 Application 2

1.4 Central Nervous System Drugs Market by Regions

1.4.1 United States Status and Prospect (2012-2022)

1.4.2 China Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 Japan Status and Prospect (2012-2022)

1.4.5 Southeast Asia Status and Prospect (2012-2022)

1.4.6 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value and Volume) of Central Nervous System Drugs (2012-2022)

1.5.1 Global Central Nervous System Drugs Sales and Growth Rate (2012-2022)

1.5.2 Global Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

2 Global Central Nervous System Drugs Competition by Manufacturers, Type and Application

2.1 Global Central Nervous System Drugs Market Competition by Manufacturers

2.1.1 Global Central Nervous System Drugs Sales and Market Share of Key Manufacturers (2012-2017)

2.1.2 Global Central Nervous System Drugs Revenue and Share by Manufacturers (2012-2017)

2.2 Global Central Nervous System Drugs (Volume and Value) by Type

2.2.1 Global Central Nervous System Drugs Sales and Market Share by Type (2012-2017)

2.2.2 Global Central Nervous System Drugs Revenue and Market Share by Type (2012-2017)

2.3 Global Central Nervous System Drugs (Volume and Value) by Regions

2.3.1 Global Central Nervous System Drugs Sales and Market Share by Regions (2012-2017)

2.3.2 Global Central Nervous System Drugs Revenue and Market Share by Regions (2012-2017)

2.4 Global Central Nervous System Drugs (Volume) by Application

3 United States Central Nervous System Drugs (Volume, Value and Sales Price)

3.1 United States Central Nervous System Drugs Sales and Value (2012-2017)

3.1.1 United States Central Nervous System Drugs Sales and Growth Rate (2012-2017)

3.1.2 United States Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

3.1.3 United States Central Nervous System Drugs Sales Price Trend (2012-2017)

3.2 United States Central Nervous System Drugs Sales and Market Share by Manufacturers

3.3 United States Central Nervous System Drugs Sales and Market Share by Type

3.4 United States Central Nervous System Drugs Sales and Market Share by Application

4 China Central Nervous System Drugs (Volume, Value and Sales Price)

4.1 China Central Nervous System Drugs Sales and Value (2012-2017)

4.1.1 China Central Nervous System Drugs Sales and Growth Rate (2012-2017)

4.1.2 China Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

4.1.3 China Central Nervous System Drugs Sales Price Trend (2012-2017)

4.2 China Central Nervous System Drugs Sales and Market Share by Manufacturers

4.3 China Central Nervous System Drugs Sales and Market Share by Type

4.4 China Central Nervous System Drugs Sales and Market Share by Application

5 Europe Central Nervous System Drugs (Volume, Value and Sales Price)

5.1 Europe Central Nervous System Drugs Sales and Value (2012-2017)

5.1.1 Europe Central Nervous System Drugs Sales and Growth Rate (2012-2017)

5.1.2 Europe Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

5.1.3 Europe Central Nervous System Drugs Sales Price Trend (2012-2017)

5.2 Europe Central Nervous System Drugs Sales and Market Share by Manufacturers

5.3 Europe Central Nervous System Drugs Sales and Market Share by Type

5.4 Europe Central Nervous System Drugs Sales and Market Share by Application

6 Japan Central Nervous System Drugs (Volume, Value and Sales Price)

6.1 Japan Central Nervous System Drugs Sales and Value (2012-2017)

6.1.1 Japan Central Nervous System Drugs Sales and Growth Rate (2012-2017)

6.1.2 Japan Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

6.1.3 Japan Central Nervous System Drugs Sales Price Trend (2012-2017)

6.2 Japan Central Nervous System Drugs Sales and Market Share by Manufacturers

6.3 Japan Central Nervous System Drugs Sales and Market Share by Type

6.4 Japan Central Nervous System Drugs Sales and Market Share by Application

7 Southeast Asia Central Nervous System Drugs (Volume, Value and Sales Price)

7.1 Southeast Asia Central Nervous System Drugs Sales and Value (2012-2017)

7.1.1 Southeast Asia Central Nervous System Drugs Sales and Growth Rate (2012-2017)

7.1.2 Southeast Asia Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

7.1.3 Southeast Asia Central Nervous System Drugs Sales Price Trend (2012-2017)

7.2 Southeast Asia Central Nervous System Drugs Sales and Market Share by Manufacturers

7.3 Southeast Asia Central Nervous System Drugs Sales and Market Share by Type

7.4 Southeast Asia Central Nervous System Drugs Sales and Market Share by Application

8 India Central Nervous System Drugs (Volume, Value and Sales Price)

8.1 India Central Nervous System Drugs Sales and Value (2012-2017)

8.1.1 India Central Nervous System Drugs Sales and Growth Rate (2012-2017)

8.1.2 India Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

8.1.3 India Central Nervous System Drugs Sales Price Trend (2012-2017)

8.2 India Central Nervous System Drugs Sales and Market Share by Manufacturers

8.3 India Central Nervous System Drugs Sales and Market Share by Type

8.4 India Central Nervous System Drugs Sales and Market Share by Application

9 Global Central Nervous System Drugs Manufacturers Analysis

9.1 Johnson & Johnson

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Central Nervous System Drugs Product Type, Application and Specification

9.1.2.1 Product A

9.1.2.2 Product B

9.1.3 Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.1.4 Main Business/Business Overview

9.2 Pfizer

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 Central Nervous System Drugs Product Type, Application and Specification

9.2.2.1 Product A

9.2.2.2 Product B

9.2.3 Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.2.4 Main Business/Business Overview

9.3 Novartis

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 Central Nervous System Drugs Product Type, Application and Specification

9.3.2.1 Product A

9.3.2.2 Product B

9.3.3 Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.3.4 Main Business/Business Overview

9.4 Roche

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Central Nervous System Drugs Product Type, Application and Specification

9.4.2.1 Product A

9.4.2.2 Product B

9.4.3 Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.4.4 Main Business/Business Overview

9.5 Sanofi-Aventis

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Central Nervous System Drugs Product Type, Application and Specification

9.5.2.1 Product A

9.5.2.2 Product B

9.5.3 Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.5.4 Main Business/Business Overview

9.6 Merck

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Central Nervous System Drugs Product Type, Application and Specification

9.6.2.1 Product A

9.6.2.2 Product B

9.6.3 Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.6.4 Main Business/Business Overview

9.7 GSK

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Central Nervous System Drugs Product Type, Application and Specification

9.7.2.1 Product A

9.7.2.2 Product B

9.7.3 GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.7.4 Main Business/Business Overview

9.8 Bayer Schering

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Central Nervous System Drugs Product Type, Application and Specification

9.8.2.1 Product A

9.8.2.2 Product B

9.8.3 Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.8.4 Main Business/Business Overview

9.9 Bristol-Myers Squibb

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Central Nervous System Drugs Product Type, Application and Specification

9.9.2.1 Product A

9.9.2.2 Product B

9.9.3 Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.9.4 Main Business/Business Overview

9.10 AbbVie

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Central Nervous System Drugs Product Type, Application and Specification

9.10.2.1 Product A

9.10.2.2 Product B

9.10.3 AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

9.10.4 Main Business/Business Overview

9.11 Eli Lilly

9.12 AstraZeneca

9.13 Takeda

9.14 Actavis

9.15 Teva

9.16 Biogen

9.17 Shire

10 Central Nervous System Drugs Maufacturing Cost Analysis

10.1 Central Nervous System Drugs Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Central Nervous System Drugs

10.3 Manufacturing Process Analysis of Central Nervous System Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Central Nervous System Drugs Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Central Nervous System Drugs Market Forecast (2017-2022)

14.1 Global Central Nervous System Drugs Sales, Revenue and Price Forecast (2017-2022)

14.1.1 Global Central Nervous System Drugs Sales and Growth Rate Forecast (2017-2022)

14.1.2 Global Central Nervous System Drugs Revenue and Growth Rate Forecast (2017-2022)

14.1.3 Global Central Nervous System Drugs Price and Trend Forecast (2017-2022)

14.2 Global Central Nervous System Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)

14.2.1 United States Central Nervous System Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.2 China Central Nervous System Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.3 Europe Central Nervous System Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.4 Japan Central Nervous System Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.5 Southeast Asia Central Nervous System Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)

14.2.6 India Central Nervous System Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)

14.3 Global Central Nervous System Drugs Sales, Revenue and Price Forecast by Type (2017-2022)

14.4 Global Central Nervous System Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Central Nervous System Drugs

Table Classification of Central Nervous System Drugs

Figure Global Sales Market Share of Central Nervous System Drugs by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Central Nervous System Drugs

Figure Global Sales Market Share of Central Nervous System Drugs by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure United States Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Figure China Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Figure Europe Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Figure Japan Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Figure Southeast Asia Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Figure India Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Figure Global Central Nervous System Drugs Sales and Growth Rate (2012-2022)

Figure Global Central Nervous System Drugs Revenue and Growth Rate (2012-2022)

Table Global Central Nervous System Drugs Sales of Key Manufacturers (2012-2017)

Table Global Central Nervous System Drugs Sales Share by Manufacturers (2012-2017)

Figure 2015 Central Nervous System Drugs Sales Share by Manufacturers

Figure 2016 Central Nervous System Drugs Sales Share by Manufacturers

Table Global Central Nervous System Drugs Revenue by Manufacturers (2012-2017)

Table Global Central Nervous System Drugs Revenue Share by Manufacturers (2012-2017)

Table 2015 Global Central Nervous System Drugs Revenue Share by Manufacturers

Table 2016 Global Central Nervous System Drugs Revenue Share by Manufacturers

Table Global Central Nervous System Drugs Sales and Market Share by Type (2012-2017)

Table Global Central Nervous System Drugs Sales Share by Type (2012-2017)

Figure Sales Market Share of Central Nervous System Drugs by Type (2012-2017)

Figure Global Central Nervous System Drugs Sales Growth Rate by Type (2012-2017)

Table Global Central Nervous System Drugs Revenue and Market Share by Type (2012-2017)

Table Global Central Nervous System Drugs Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Central Nervous System Drugs by Type (2012-2017)

Figure Global Central Nervous System Drugs Revenue Growth Rate by Type (2012-2017)

Table Global Central Nervous System Drugs Sales and Market Share by Regions (2012-2017)

Table Global Central Nervous System Drugs Sales Share by Regions (2012-2017)

Figure Sales Market Share of Central Nervous System Drugs by Regions (2012-2017)

Figure Global Central Nervous System Drugs Sales Growth Rate by Regions (2012-2017)

Table Global Central Nervous System Drugs Revenue and Market Share by Regions (2012-2017)

Table Global Central Nervous System Drugs Revenue Share by Regions (2012-2017)

Figure Revenue Market Share of Central Nervous System Drugs by Regions (2012-2017)

Figure Global Central Nervous System Drugs Revenue Growth Rate by Regions (2012-2017)

Table Global Central Nervous System Drugs Sales and Market Share by Application (2012-2017)

Table Global Central Nervous System Drugs Sales Share by Application (2012-2017)

Figure Sales Market Share of Central Nervous System Drugs by Application (2012-2017)

Figure Global Central Nervous System Drugs Sales Growth Rate by Application (2012-2017)

Figure United States Central Nervous System Drugs Sales and Growth Rate (2012-2017)

Figure United States Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

Figure United States Central Nervous System Drugs Sales Price Trend (2012-2017)

Table United States Central Nervous System Drugs Sales by Manufacturers (2012-2017)

Table United States Central Nervous System Drugs Market Share by Manufacturers (2012-2017)

Table United States Central Nervous System Drugs Sales by Type (2012-2017)

Table United States Central Nervous System Drugs Market Share by Type (2012-2017)

Table United States Central Nervous System Drugs Sales by Application (2012-2017)

Table United States Central Nervous System Drugs Market Share by Application (2012-2017)

Figure China Central Nervous System Drugs Sales and Growth Rate (2012-2017)

Figure China Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

Figure China Central Nervous System Drugs Sales Price Trend (2012-2017)

Table China Central Nervous System Drugs Sales by Manufacturers (2012-2017)

Table China Central Nervous System Drugs Market Share by Manufacturers (2012-2017)

Table China Central Nervous System Drugs Sales by Type (2012-2017)

Table China Central Nervous System Drugs Market Share by Type (2012-2017)

Table China Central Nervous System Drugs Sales by Application (2012-2017)

Table China Central Nervous System Drugs Market Share by Application (2012-2017)

Figure Europe Central Nervous System Drugs Sales and Growth Rate (2012-2017)

Figure Europe Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

Figure Europe Central Nervous System Drugs Sales Price Trend (2012-2017)

Table Europe Central Nervous System Drugs Sales by Manufacturers (2012-2017)

Table Europe Central Nervous System Drugs Market Share by Manufacturers (2012-2017)

Table Europe Central Nervous System Drugs Sales by Type (2012-2017)

Table Europe Central Nervous System Drugs Market Share by Type (2012-2017)

Table Europe Central Nervous System Drugs Sales by Application (2012-2017)

Table Europe Central Nervous System Drugs Market Share by Application (2012-2017)

Figure Japan Central Nervous System Drugs Sales and Growth Rate (2012-2017)

Figure Japan Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

Figure Japan Central Nervous System Drugs Sales Price Trend (2012-2017)

Table Japan Central Nervous System Drugs Sales by Manufacturers (2012-2017)

Table Japan Central Nervous System Drugs Market Share by Manufacturers (2012-2017)

Table Japan Central Nervous System Drugs Sales by Type (2012-2017)

Table Japan Central Nervous System Drugs Market Share by Type (2012-2017)

Table Japan Central Nervous System Drugs Sales by Application (2012-2017)

Table Japan Central Nervous System Drugs Market Share by Application (2012-2017)

Figure Southeast Asia Central Nervous System Drugs Sales and Growth Rate (2012-2017)

Figure Southeast Asia Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

Figure Southeast Asia Central Nervous System Drugs Sales Price Trend (2012-2017)

Table Southeast Asia Central Nervous System Drugs Sales by Manufacturers (2012-2017)

Table Southeast Asia Central Nervous System Drugs Market Share by Manufacturers (2012-2017)

Table Southeast Asia Central Nervous System Drugs Sales by Type (2012-2017)

Table Southeast Asia Central Nervous System Drugs Market Share by Type (2012-2017)

Table Southeast Asia Central Nervous System Drugs Sales by Application (2012-2017)

Table Southeast Asia Central Nervous System Drugs Market Share by Application (2012-2017)

Figure India Central Nervous System Drugs Sales and Growth Rate (2012-2017)

Figure India Central Nervous System Drugs Revenue and Growth Rate (2012-2017)

Figure India Central Nervous System Drugs Sales Price Trend (2012-2017)

Table India Central Nervous System Drugs Sales by Manufacturers (2012-2017)

Table India Central Nervous System Drugs Market Share by Manufacturers (2012-2017)

Table India Central Nervous System Drugs Sales by Type (2012-2017)

Table India Central Nervous System Drugs Market Share by Type (2012-2017)

Table India Central Nervous System Drugs Sales by Application (2012-2017)

Table India Central Nervous System Drugs Market Share by Application (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Johnson & Johnson Central Nervous System Drugs Global Market Share (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Pfizer Central Nervous System Drugs Global Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis Central Nervous System Drugs Global Market Share (2012-2017)

Table Roche Basic Information List

Table Roche Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Roche Central Nervous System Drugs Global Market Share (2012-2017)

Table Sanofi-Aventis Basic Information List

Table Sanofi-Aventis Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Sanofi-Aventis Central Nervous System Drugs Global Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Merck Central Nervous System Drugs Global Market Share (2012-2017)

Table GSK Basic Information List

Table GSK Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure GSK Central Nervous System Drugs Global Market Share (2012-2017)

Table Bayer Schering Basic Information List

Table Bayer Schering Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Bayer Schering Central Nervous System Drugs Global Market Share (2012-2017)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb Central Nervous System Drugs Global Market Share (2012-2017)

Table AbbVie Basic Information List

Table AbbVie Central Nervous System Drugs Sales, Revenue, Price and Gross Margin (2012-2017)

Figure AbbVie Central Nervous System Drugs Global Market Share (2012-2017)

Table Eli Lilly Basic Information List

Table AstraZeneca Basic Information List

Table Takeda Basic Information List

Table Actavis Basic Information List

Table Teva Basic Information List

Table Biogen Basic Information List

Table Shire Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Central Nervous System Drugs

Figure Manufacturing Process Analysis of Central Nervous System Drugs

Figure Central Nervous System Drugs Industrial Chain Analysis

Table Raw Materials Sources of Central Nervous System Drugs Major Manufacturers in 2015

Table Major Buyers of Central Nervous System Drugs

Table Distributors/Traders List

Figure Global Central Nervous System Drugs Sales and Growth Rate Forecast (2017-2022)

Figure Global Central Nervous System Drugs Revenue and Growth Rate Forecast (2017-2022)

Table Global Central Nervous System Drugs Sales Forecast by Regions (2017-2022)

Table Global Central Nervous System Drugs Sales Forecast by Type (2017-2022)

Table Global Central Nervous System Drugs Sales Forecast by Application (2017-2022)